Intravascular Hemolysis After Transcatheter Aortic Valve Implantation in patients with Severe Aortic Stenosis: Observational, multicenter, prospective study

Intravascular Hemolysis After Transcatheter Aortic Valve Implantation in patients with Severe Aortic Stenosis: Observational, multicenter, prospective study - Intravascular Hemolysis After TAVI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046891

Enrollment

300

Registered

2022-04-01

Start date

2022-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Aortic Stenosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who underwent transcatheter aortic valve implantation 2. Patients with over 20 years old 3. Patients who agree to be enrolled for the trial gave signed written informed consent

Exclusion criteria

Exclusion criteria: Any patients who are judged inappropriate by research director or co-investigators

Design outcomes

Primary

Measure	Time frame
The frequency of the patients with intravascular hemolysis for one year after transcatheter aortic valve implantation	—

Secondary

Measure	Time frame
The frequency of cardiovascular readmission and cardiovascular death at one year in patients with intravascular hemolysis after transcatheter aortic valve implantation	—

Countries

Japan

Contacts

Public ContactHiroyuki Kawamori

Kobe University Hospital Department of Cardiovascular Medicine

hiroyuki@med.kobe-u.ac.jp0783825846

Outcome results